Autobio Diagnostics Co (SHSE:603658) Accounts Payable & Accrued Expense : ¥1,390 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Autobio Diagnostics Co Accounts Payable & Accrued Expense?

Autobio Diagnostics Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥1,486 Mil) to Dec. 2023 (¥1,618 Mil) but then declined from Dec. 2023 (¥1,618 Mil) to Mar. 2024 (¥1,390 Mil).

Autobio Diagnostics Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥1,112 Mil) to Dec. 2022 (¥1,889 Mil) but then declined from Dec. 2022 (¥1,889 Mil) to Dec. 2023 (¥1,618 Mil).

Autobio Diagnostics Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Autobio Diagnostics Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autobio Diagnostics Co Accounts Payable & Accrued Expense Chart

Autobio Diagnostics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

625.83

954.79

1,112.05

1,889.39

1,617.80

Autobio Diagnostics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,438.24	1,474.24	1,485.54	1,617.80	1,390.13

Autobio Diagnostics Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Autobio Diagnostics Co (SHSE:603658) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autobio Diagnostics Co Ltd (SHSE:603658) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.199, 15th Avenue, National Economic and Technological Development Area, Zhengzhou, CHN, 450016

Website

http://www.autobio.com.cn

Autobio Diagnostics Co Ltd is a clinical diagnostics company in China. It specializes in research and development, production, marketing and service of clinical diagnostic products, including immunoassay, microbiology and biochemical products. It focuses on the common development of both reagents and instruments. Reagents products include immunoassay, biochemistry, microbiology, and IVD subdivision areas, and instruments include both full automation and semi-automation instruments and systems. Geographically it holds a strong distribution network with thousands of distributors in the Chinese market.

Executives

Miao Yong Jun

Director

Autobio Diagnostics Co (SHSE:603658) Headlines

No Headlines